In Brief: Laser Industries
This article was originally published in The Gray Sheet
Executive Summary
Laser Industries: Firm submits investigational device exemption seeking FDA approval to conduct clinical trials of its Sharplan holmium laser in conjunction with a Biosense catheter-based cardiovascular navigation system to perform direct myocardial revascularization (DMR). The minimally invasive procedure intended to relieve angina pain by increasing blood flow to ischemic heart muscles has been undergoing pre-clinical trials for the past year. Laser Industries and Biosense are jointly developing the technology...